* Beauty Health Co SKIN.OQ SKIN.O is expected to show a
rise
in quarterly revenue when it reports results
* The Long Beach California-based company is expected to
report
a 30.9% increase in revenue to $116.212 million from $88.79
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data.
* Refinitiv's mean analyst estimate for Beauty Health Co is
for
earnings of 9 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Beauty
Health Co
is $10.75, above its last closing price of $3.97.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.05 0.06 0.17 Beat 209.1
Mar. 31 2023 -0.02 -0.02 -0.04 Missed -80
Dec. 31 2022 0.04 0.04 0.05 Beat 32.4
Sep. 30 2022 0.02 0.02 0.05 Beat 164.7
Jun. -0.01 0.00 0.01 Beat 1,000.
30 2022 9
Mar. 31 2022 -0.01 0.00 0.22 Beat 5,600
Dec. 31 2021 -0.02 -0.02 -0.12 Missed -535.3
Sep. 30 2021 -0.02 -0.01 -1.63 Missed -11,75
4.5
This summary was machine generated November 3 at 18:30 GMT. All
figures in US dollars unless otherwise stated